Viewing Study NCT00412867


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-02-02 @ 3:16 AM
Study NCT ID: NCT00412867
Status: COMPLETED
Last Update Posted: 2018-01-19
First Post: 2006-12-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Japan Alteplase Clinical Trial Ⅱ:J-ACT Ⅱ)
Sponsor: Tanabe Pharma Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stroke View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cerebral Infarction View
None acute ischemic stroke View
None Brain ischemia View